Medical Developments International Limited
MVP
Rangering i aksjer
#27440
Medical Developments International Limited (MDIL) specializes in the... Medical Developments International Limited (MDIL) specializes in the development and provision of essential emergency medical solutions, serving global markets including Australia, Europe, and the United States. The company's operations are divided into two primary segments: Pain Management and Respiratory care. Among its key offerings is Penthrox, a product specifically formulated for rapid pain relief in acute trauma and emergency situations. Within the respiratory segment, MDIL supplies equipment designed to assist individuals with conditions like asthma and chronic obstructive pulmonary disease (COPD). Additionally, its comprehensive portfolio features a diverse array of medical devices, encompassing items such as CPR face shields and masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, oxygen resuscitation kits, and various oxygen therapy and resuscitation apparatus. Established in 2003, the company maintains its headquarters in Scoresby, Australia.
Aksjekurs
$0.27858749
Markedsverdi
$31.39M
Endring (1 dag)
-1.25%
Endring (1 år)
-13.10%
Land
AU
Handel Medical Developments International Limited (MVP)
Kategori
Healthcare
Markedsverdi av Medical Developments International Limited(MVP)
Markedsverdi: $31.39M
Per October 2026 har Medical Developments International Limited en markedsverdi på $31.39M. Dette gjør Medical Developments International Limited til det 27440th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Medical Developments International Limited fra 2020 til 2026
MVP sammenlignet med topp 5 mest populære stocks
